
Profound Medical Corp. PROF
€ 5.30
4.12%
Geschäftsbericht 2023
hinzugefügt 27.12.2025
Profound Medical Corp. Betriebsaufwand 2011-2026 | PROF
Betriebsaufwand Jährlich Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33 M | 35.1 M | 33.2 M | 22.3 M | 17.3 M | 21 M | 19.5 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 35.1 M | 17.3 M | 25.9 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
614 M | $ 11.23 | 2.98 % | $ 1.69 B | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.6 | -2.21 % | $ 37.3 M | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.38 | 2.42 % | $ 127 M | ||
|
AxoGen
AXGN
|
121 M | $ 33.1 | 3.58 % | $ 1.52 B | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.98 | 4.76 % | $ 1.2 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Align Technology
ALGN
|
2.19 B | $ 179.71 | 3.79 % | $ 13.5 B | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.27 | 0.78 % | $ 1.66 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.03 | 3.01 % | $ 17.4 M | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
1.03 B | $ 287.85 | 3.08 % | $ 8.12 B | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
1.4 B | $ 39.15 | 4.15 % | $ 5.83 K | ||
|
LivaNova PLC
LIVN
|
697 M | $ 64.37 | 2.53 % | $ 3.51 B | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.85 | 2.63 % | $ 70 M | ||
|
Boston Scientific Corporation
BSX
|
10.2 B | $ 63.07 | 2.07 % | $ 93.4 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 9.86 | 13.59 % | $ 279 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
40.3 M | $ 24.67 | 2.28 % | $ 209 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Inogen
INGN
|
184 M | $ 6.42 | 1.42 % | $ 171 M | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.85 | 5.51 % | $ 395 M | ||
|
Globus Medical
GMED
|
547 M | $ 92.7 | 2.52 % | $ 12.5 B | ||
|
Butterfly Network
BFLY
|
123 M | $ 4.27 | 3.89 % | $ 904 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
Stryker Corporation
SYK
|
11.2 B | $ 345.88 | 1.98 % | $ 132 B | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
TELA Bio
TELA
|
88.1 M | $ 0.56 | -1.34 % | $ 26.3 M | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 10.45 | 4.03 % | $ 374 M | ||
|
Myomo
MYO
|
41.3 M | $ 0.72 | 4.09 % | $ 30.1 M | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 54.5 | 0.89 % | $ 1.6 B | ||
|
TransMedics Group
TMDX
|
254 M | $ 113.16 | -0.74 % | $ 3.85 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 38.31 | 4.27 % | $ 1.19 B |